These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 9831071

  • 21. DNA bending is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements.
    Kimmel-Jehan C, Darwish HM, Strugnell SA, Jehan F, Wiefling B, DeLuca HF.
    J Cell Biochem; 1999 Aug 01; 74(2):220-8. PubMed ID: 10404392
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators.
    Herdick M, Carlberg C.
    J Mol Biol; 2000 Dec 15; 304(5):793-801. PubMed ID: 11124027
    [Abstract] [Full Text] [Related]

  • 30. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
    Yang L, Yang J, Venkateswarlu S, Ko T, Brattain MG.
    J Cell Physiol; 2001 Sep 15; 188(3):383-93. PubMed ID: 11473365
    [Abstract] [Full Text] [Related]

  • 31. Allosteric interaction of the 1alpha,25-dihydroxyvitamin D3 receptor and the retinoid X receptor on DNA.
    Kahlen JP, Carlberg C.
    Nucleic Acids Res; 1997 Nov 01; 25(21):4307-13. PubMed ID: 9336462
    [Abstract] [Full Text] [Related]

  • 32. Two nuclear signalling pathways for vitamin D.
    Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF, Hunziker W.
    Nature; 1993 Feb 18; 361(6413):657-60. PubMed ID: 8382345
    [Abstract] [Full Text] [Related]

  • 33. The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings.
    Verstuyf A, Verlinden L, Van Baelen H, Sabbe K, D'Hallewyn C, De Clercq P, Vandewalle M, Bouillon R.
    J Bone Miner Res; 1998 Apr 18; 13(4):549-58. PubMed ID: 9556055
    [Abstract] [Full Text] [Related]

  • 34. Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation.
    Schräder M, Nayeri S, Kahlen JP, Müller KM, Carlberg C.
    Mol Cell Biol; 1995 Mar 18; 15(3):1154-61. PubMed ID: 7862109
    [Abstract] [Full Text] [Related]

  • 35. Synthetic LXXLL peptide antagonize 1,25-dihydroxyvitamin D3-dependent transcription.
    Pike JW, Pathrose P, Barmina O, Chang CY, McDonnell DP, Yamamoto H, Shevde NK.
    J Cell Biochem; 2003 Feb 01; 88(2):252-8. PubMed ID: 12520523
    [Abstract] [Full Text] [Related]

  • 36. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
    González-Avión XC, Mouriño A, Rochel N, Moras D.
    J Med Chem; 2006 Mar 09; 49(5):1509-16. PubMed ID: 16509569
    [Abstract] [Full Text] [Related]

  • 37. Vitamin D receptor-DNA interactions.
    Shaffer PL, Gewirth DT.
    Vitam Horm; 2004 Mar 09; 68():257-73. PubMed ID: 15193458
    [Abstract] [Full Text] [Related]

  • 38. Molecular evaluation of vitamin D3 receptor agonists designed for topical treatment of skin diseases.
    Bury Y, Ruf D, Hansen CM, Kissmeyer AM, Binderup L, Carlberg C.
    J Invest Dermatol; 2001 May 09; 116(5):785-92. PubMed ID: 11348471
    [Abstract] [Full Text] [Related]

  • 39. Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor.
    Liu YY, Nguyen C, Peleg S.
    Mol Endocrinol; 2000 Nov 09; 14(11):1776-87. PubMed ID: 11075811
    [Abstract] [Full Text] [Related]

  • 40. Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors.
    Fernandez-Martin JL, Kurian S, Farmer P, Nanes MS.
    Mol Cell Endocrinol; 1998 Jun 25; 141(1-2):65-72. PubMed ID: 9723887
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.